LBRX News

LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices

LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer

LB Pharmaceuticals Announces Presentation at the Stifel 2025 Healthcare Conference

LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates